Title : No Evidence for Drug-Specific Activation of Circulating T Cells from Patients with HLA-DRB1*07:01-Restricted Lapatinib-Induced Liver Injury.

Pub. Date : 2016 Dec 19

PMID : 27989141






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 It is hypothesized that lapatinib-induced liver injury is caused by HLA-mediated antigen presentation to CD4 positive T cells. Lapatinib major histocompatibility complex, class II, DR beta 1 Homo sapiens
2 However, analysis of PBMC and cloned T-cells from patients with HLA-DRB1*07:01-restricted lapatinib-induced liver injury revealed no evidence for drug-specific activation. Lapatinib major histocompatibility complex, class II, DR beta 1 Homo sapiens